Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:
- an article suggesting the Federal Circuit in a recent opinion “explored and clarified” the limits on how a court can correct errors in patents;
- a blog post indicating another recent Federal Circuit decision answers the question of “[w]hat value” a patent has when it “expires before it issues”;
- an article explaining how the Supreme Court’s “unanimous decision in Hikma v. Amarin fundamentally altered the legal landscape for generic pharmaceutical manufacturers, imposing a stricter standard for what constitutes patent infringement liability and potentially clearing a path for lower-cost alternatives to reach patients sooner”; and
- an article arguing President Trump’s “new Section 301 tariffs . . . run afoul of the major questions doctrine, which requires Congress to ‘speak clearly’ when authorizing the executive to make decisions of ‘vast economic and political significance.’”
